Advertisement
Advertisement
U.S. Markets open in 25 mins
S&P Futures
3,921.50 +5.25 (+0.13%) Dow Futures
31,509.00 +22.00 (+0.07%) Nasdaq Futures
12,159.25 +18.75 (+0.15%) Russell 2000 Futures
1,764.50 +2.80 (+0.16%) Crude Oil
107.90 +0.28 (+0.26%) Gold
1,832.30 +2.00 (+0.11%)
Arena Pharmaceuticals, Inc. (ARNA)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 05:00PM EDT
Advertisement
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 99.99 |
| Open | 99.97 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 3200 |
| Day's Range | 99.97 - 100.00 |
| 52 Week Range | 45.50 - 100.00 |
| Volume | |
| Avg. Volume | 1,472,638 |
| Market Cap | 6.156B |
| Beta (5Y Monthly) | 0.55 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -9.72 |
| Earnings Date | Feb 21, 2022 - Feb 25, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 97.86 |
- Zacks
Are Options Traders Betting on a Big Move in Arena (ARNA) Stock?
Investors need to pay close attention to Arena (ARNA) stock based on the movements in the options market lately.
- Zacks
Arena (ARNA) Q4 Loss Wider Than Expected, Etrasimod in Focus
Arena Pharmaceuticals (ARNA) misses on Q4 bottom line. Top-line data from several phase III studies on etrasimod are slated for release in 2022.
- Business Wire
Arena Reports Fourth Quarter and Full Year 2021 Financial Results and Key Program Updates
PARK CITY, Utah, February 23, 2022--Arena Pharmaceuticals today provided a corporate update and reported financial results for the fourth quarter and full year ended December 31, 2021
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2022 Yahoo. All rights reserved.
